Press Releases about Virpax Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20230621301923/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230620765985/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Announces CFO Transition
June 20, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230613519555/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230512005074/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230510005064/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230504005184/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230427005165/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230405005074/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230328005102/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230322005082/en/1691926/22/Logo_01_20_2023.jpg)
Virpax Pharmaceuticals Reports 2022 Year-End Results
March 22, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230213005043/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230131005119/en/1691926/22/Logo_01_20_2023.jpg)
![](https://mms.businesswire.com/media/20230118005154/en/1688260/22/New_Logo.jpg)
![](https://mms.businesswire.com/media/20230110005174/en/1680856/22/New_Logo.jpg)
![](https://mms.businesswire.com/media/20230104005063/en/1674833/22/New_Logo.jpg)
![](https://mms.businesswire.com/media/20221214005204/en/1663889/22/New_Logo.jpg)
![](https://mms.businesswire.com/media/20221109005109/en/1629715/4/New_Logo.jpg)
Virpax Pharmaceuticals Reports 2022 Third Quarter Results
November 09, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220824005061/en/1551202/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220815005046/en/1542971/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220705005088/en/1503194/4/New_Logo.jpg)
Virpax Pursues OTC Medical Device Pathway for AnQlar™
July 05, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220627005164/en/1497054/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220519005105/en/1460089/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220516005060/en/1454815/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220505005208/en/1444097/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220426005104/en/1430961/4/New_Logo.jpg)
![](https://mms.businesswire.com/media/20220331005070/en/1405350/4/New_Logo.jpg)
Virpax Pharmaceuticals Reports 2021 Year-End Results
March 31, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220322005148/en/1395911/4/New_Logo.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/24445.png?v=0)
From Nanomerics Ltd
Via AccessWire
![](https://mms.businesswire.com/media/20220315005253/en/1389130/4/New_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.